Source

TECH ANALYSIS _ NIFTY SPOT_03.01.2022

SEBI: Lock-in period for anchor investors in IPOs raised to 90 days

Sun Pharma: Got DCGI OK for Molnupiravir drug in India

Granules India: Got US FDA OK for Prazosin Hydrochloride capsules

Supriya Lifescience shares list at 425 rupees on BSE issue price 274 rupees

BSE board to mull bonus share issue on Feb 8

Pre-Open Tech View –Nifty & Bank Nifty Spot_28.12.2021

Pre-Open Daily Trading ideas of Nifty & Bank Nifty Spot

Weekly Tech Analysis Nifty Spot_ 27.12.2021